plasma
-
not specified
RT-qPCR; RNase R Treatment; ROC Analysis; Bioinformatics Analysis; Clinical Sample Validation
May serve as a plasma fingerprint/marker for predicting the occurrence of GBM; used in a diagnostic risk score model with ROC AUC reported.
circFOXO3 is up-regulated in GBM patient plasma and was selected in the validation set as a potential circulating fingerprint for predicting GBM occurrence, contributing to a multi-circRNA diagnostic risk score with high AUC.
0.559
Plasmatic circRNA Predicting the Occurrence of Human Glioblastoma.
combined biological and clinical study